• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本,慢性病的存在是妇科癌症发生风险因素之一。

The presence of chronic diseases contributes to the occurrence risk factors for gynecological cancers in Japan.

作者信息

Okamoto Kazuhiro, Nakamura Keiichiro, Matsuoka Hirofumi, Matsubara Yuko, Haraga Junko, Ogawa Chikako, Masuyama Hisashi

机构信息

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama 700-8558, Japan.

出版信息

Mol Clin Oncol. 2020 Apr;12(4):336-342. doi: 10.3892/mco.2020.1989. Epub 2020 Jan 29.

DOI:10.3892/mco.2020.1989
PMID:32190316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7057916/
Abstract

The aim of the present study was to determine whether chronic diseases (CD), such as hypertension, diabetes mellitus, dyslipidemia, heart diseases and cerebrovascular diseases, are occurrence risk factors and affect the survival of patients with gynecological cancers (GC). The correlations between CD and the characteristics and survival of 1,590 GC patients [685 with cervical cancer (CC), 613 with endometrial cancer (EM) and 292 with ovarian cancer (OV)] were investigated in the present study. Of the CD patients, 189 had CC (27.6%), 265 had EM (43.2%) and 72 had OV (24.7%). The incidence of CD increased with age in GC patients. The number of CD patients aged ≥70 years, was 8.6-fold higher in the CC group, 3.0-fold higher in the EM group, and 9.6-fold higher in the OV group compared with those aged <50 years. CD and excess body weight were associated with GC regardless of patient age. However, there was no correlation between CD and survival at any age in GC patients. These findings indicate that CD contribute to >24% of the occurrence risk factors in GC patients in Japan.

摘要

本研究的目的是确定诸如高血压、糖尿病、血脂异常、心脏病和脑血管疾病等慢性病(CD)是否为发生风险因素,并影响妇科癌症(GC)患者的生存。本研究调查了CD与1590例GC患者[685例宫颈癌(CC)、613例子宫内膜癌(EM)和292例卵巢癌(OV)]的特征及生存之间的相关性。在CD患者中,189例患有CC(27.6%),265例患有EM(43.2%),72例患有OV(24.7%)。GC患者中CD的发病率随年龄增长而增加。与年龄<50岁的患者相比,≥70岁的CD患者数量在CC组中高8.6倍,在EM组中高3.0倍,在OV组中高9.6倍。无论患者年龄如何,CD和超重均与GC相关。然而,在GC患者中,CD与任何年龄的生存均无相关性。这些发现表明,在日本,CD占GC患者发生风险因素的比例超过24%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/7f41ec075ea4/mco-12-04-0336-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/de05eeb14d70/mco-12-04-0336-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/b3d624c708be/mco-12-04-0336-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/7f41ec075ea4/mco-12-04-0336-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/de05eeb14d70/mco-12-04-0336-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/b3d624c708be/mco-12-04-0336-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717c/7057916/7f41ec075ea4/mco-12-04-0336-g02.jpg

相似文献

1
The presence of chronic diseases contributes to the occurrence risk factors for gynecological cancers in Japan.在日本,慢性病的存在是妇科癌症发生风险因素之一。
Mol Clin Oncol. 2020 Apr;12(4):336-342. doi: 10.3892/mco.2020.1989. Epub 2020 Jan 29.
2
Risk of Gynecologic Cancer as Second versus First Primary Cancer in Japan.日本女性生殖系统癌症作为第二原发癌与第一原发癌的风险。
Acta Med Okayama. 2020 Apr;74(2):109-114. doi: 10.18926/AMO/58268.
3
Net Survival of Elderly Patients with Gynecological Cancer Aged Over 75 Years in 2006-2008.2006 - 2008年75岁以上老年妇科癌症患者的净生存率
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):437-442. doi: 10.31557/APJCP.2019.20.2.437.
4
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.妇科癌症或良性妇科疾病患者术前采集血浆中的可溶性尿激酶型纤溶酶原激活物受体
Gynecol Oncol. 2001 Sep;82(3):523-31. doi: 10.1006/gyno.2001.6324.
5
CYP1A1 polymorphism and risk of gynecological malignancy in Japan.CYP1A1基因多态性与日本妇科恶性肿瘤风险
Int J Gynecol Cancer. 2003 Nov-Dec;13(6):785-90. doi: 10.1111/j.1525-1438.2003.13607.x.
6
Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?土耳其妇科癌症趋势:走向欧洲还是亚洲?
Int J Gynecol Cancer. 2017 Oct;27(8S):S1-S9. doi: 10.1136/ijgc-00009577-201710001-00001.
7
Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?土耳其妇科癌症趋势:走向欧洲还是亚洲?
Int J Gynecol Cancer. 2017 Oct;27(8S Suppl 1):S1-S9. doi: 10.1097/IGC.0000000000001026.
8
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.与子宫内膜样癌相比,浆液性乳头状癌和透明细胞癌的流行病学及外科病理特征。
Gynecol Oncol. 1999 Sep;74(3):385-94. doi: 10.1006/gyno.1999.5505.
9
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.与子宫内膜样癌相比,I-II期经临床和手术分期的浆液性乳头状和透明细胞子宫内膜癌的结局。
Gynecol Oncol. 2000 Apr;77(1):55-65. doi: 10.1006/gyno.2000.5737.
10
Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.妇科癌症中人乳头瘤病毒DNA水平的比较:对癌症发展的影响。
Tumour Biol. 2003 Nov-Dec;24(6):310-6. doi: 10.1159/000076463.

本文引用的文献

1
Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.日本妇科肿瘤学会 2017 年子宫颈癌治疗指南。
Int J Clin Oncol. 2019 Jan;24(1):1-19. doi: 10.1007/s10147-018-1351-y. Epub 2018 Oct 5.
2
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.饮酒风险阈值:83 项前瞻性研究中 599912 名当前饮酒者的个体参与者数据的综合分析。
Lancet. 2018 Apr 14;391(10129):1513-1523. doi: 10.1016/S0140-6736(18)30134-X.
3
Cancer risk associated with chronic diseases and disease markers: prospective cohort study.
与慢性病和疾病标志物相关的癌症风险:前瞻性队列研究。
BMJ. 2018 Jan 31;360:k134. doi: 10.1136/bmj.k134.
4
Effects of high alcohol intake, alcohol-related symptoms and smoking on mortality.高酒精摄入量、与酒精相关的症状和吸烟对死亡率的影响。
Addiction. 2018 Jan;113(1):158-166. doi: 10.1111/add.14008. Epub 2017 Sep 18.
5
Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.用于预测上皮性卵巢癌生存率的代谢谱分析及新型血浆生物标志物
Oncotarget. 2017 May 9;8(19):32134-32146. doi: 10.18632/oncotarget.16739.
6
Case-control study of metabolic syndrome and ovarian cancer in Chinese population.中国人群中代谢综合征与卵巢癌的病例对照研究。
Nutr Metab (Lond). 2017 Feb 28;14:21. doi: 10.1186/s12986-017-0176-4. eCollection 2017.
7
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.日本妇科肿瘤学会2015年卵巢癌(包括原发性腹膜癌和输卵管癌)治疗指南
Int J Clin Oncol. 2016 Jun;21(3):435-46. doi: 10.1007/s10147-016-0985-x. Epub 2016 May 3.
8
Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms.日本妇科肿瘤学会2013年子宫体肿瘤治疗指南
Int J Clin Oncol. 2016 Jun;21(3):419-34. doi: 10.1007/s10147-016-0981-1. Epub 2016 Apr 26.
9
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.肥胖与卵巢癌女性患者的生存率:卵巢癌协会联盟的研究结果
Br J Cancer. 2015 Sep 1;113(5):817-26. doi: 10.1038/bjc.2015.245. Epub 2015 Jul 7.
10
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.2009年日本的癌症发病率及发生率:针对日本癌症发病率监测(MCIJ)项目的32个基于人群的癌症登记处的研究。
Jpn J Clin Oncol. 2015 Sep;45(9):884-91. doi: 10.1093/jjco/hyv088. Epub 2015 Jul 3.